• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

CECP's CEO Investor Forum and Biopharma Sustainability Roundtable Release Report on Integrating Sustainability and Long-Term Planning for the Biopharma Sector


Research shows ESG performance is strongly predictive of long-term value creation and financial performance, when a sector-specific approach is maintained.

As the world begins to emerge from under the weight of multiple crises, investors are seeking more effective and efficient ESG (environment, social, and governance) communications directly from companies, which include a longer-term strategy and vision. Answering that call, Chief Executives for Corporate Purpose’s (CECP) CEO Investor Forum, an advisor that empowers CEOs on their journey to refocus investor expectations toward the long term, and the Biopharma Sustainability Roundtable (BSRT), a sector-specific collaboration platform that works with senior biotech and pharma executives to help drive their sustainability agendas forward, released a joint report on Integrating Sustainability and Long-Term Planning for the Biopharma Sector.

The new report, together with a companion practitioner’s guide, provide sector-specific tools for biopharma CEOs and their teams as they prepare sustainable Long-Term Plans to share with investors. Combining CECP’s Long-Term Plan framework and BSRT’s Biopharma Investor ESG Communications Guidance will help tailor content and perspective for the biopharma sector.

For more information and the full report, click here.

Related Videos